Multi-peptide Vaccination Adjuvanted With XS15 in Acute Myeloid Leukemia Patients

NCT06252584 · PHASE1 · RECRUITING · Sponsor: University Hospital Tuebingen · Conditions: Acute Myeloid Leukemia,

By Priya Raman · Science Reporter

Nov 9 07:00 ETSource: ClinicalTrials.gov

From the source

Multi-peptide Vaccination Adjuvanted With XS15 in Acute Myeloid Leukemia Patients
NCT06252584 · PHASE1 · RECRUITING · Sponsor: University Hospital Tuebingen · Conditions: Acute Myeloid Leukemia, Adult.

Read at clinicaltrials.gov

Source URL https://clinicaltrials.gov/study/NCT06252584